Weekly exposure (57 days/week) Weekly Exposure From the 1:1 Pre-blended Vial Daily blend dose 0.5 mg/day Weekly total blend 2.53.5 mg Weekly BPC-157 1.251.75 mg Weekly TB-500 1.251.75 mg Daily blend dose 1.0 mg/day Weekly total blend 5.07.0 mg Weekly BPC-157 2.53.5 mg Weekly TB-500 2.53.5 mg Daily blend dose 1.5 mg/day Weekly total blend 7.510.5 mg Weekly BPC-157 3.755.25 mg Weekly TB-500 3.755.25 mg Daily blend dose 2.0 mg/day Weekly total blend 10.014.0 mg Weekly BPC-157 5.07.0 mg Weekly TB-500 5.07.0 mg Use this to compare a blend schedule against the separate-vial weekly totals in the next tab
18 Intranasal administration of reduced GSH, (in)GSH, could be an effective approach for delivery of GSH to the CNS
R Sinha 1, I Sinha 1, A Calcagnotto 2, N Trushin 2, J S Haley 3, T D Schell 3, J P Richie J Eur J Clin Nutr
The final piece of a syringe is the plunger
Your body will thank you
The GLOW Blend's value lies not in any therapeutic claims but rather in its utility as a comprehensive research platform for studying the molecular mechanisms of tissue regeneration, cellular plasticity, and aging-related changes across multiple biological systems